Goldman Sachs ActiveBeta International Equity ETF (GSIE)
| Assets | $3.99B |
| Expense Ratio | 0.25% |
| PE Ratio | 15.44 |
| Shares Out | 102.90M |
| Dividend (ttm) | $1.14 |
| Dividend Yield | 2.95% |
| Ex-Dividend Date | Jun 24, 2025 |
| Payout Ratio | 41.07% |
| 1-Year Return | +15.02% |
| Volume | 318,746 |
| Open | 38.80 |
| Previous Close | 39.00 |
| Day's Range | 38.73 - 38.87 |
| 52-Week Low | 31.73 |
| 52-Week High | 39.93 |
| Beta | 0.84 |
| Holdings | 658 |
| Inception Date | Nov 6, 2015 |
About GSIE
Fund Home PageThe Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of stocks in developed markets outside of the US comprising four sub-indices: value, momentum, quality and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight GSIE was launched on Nov 6, 2015 and is issued by Goldman Sachs.
Top 10 Holdings
10.78% of assets| Name | Symbol | Weight |
|---|---|---|
| USD U.S. DOLLAR | -- | 2.50% |
| SAP SE | SAP | 1.13% |
| ASML Holding N.V. | ASML | 1.09% |
| Novartis AG | NOVN | 0.99% |
| Roche Holding AG | ROG | 0.96% |
| Nestlé S.A. | NESN | 0.86% |
| Novo Nordisk A/S | NOVO.B | 0.85% |
| HSBC Holdings plc | HSBA | 0.84% |
| Royal Bank of Canada | RY | 0.81% |
| AstraZeneca PLC | AZN | 0.75% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 24, 2025 | $0.56325 | Jun 30, 2025 |
| Mar 25, 2025 | $0.13089 | Mar 31, 2025 |
| Dec 31, 2024 | $0.04259 | Jan 7, 2025 |
| Dec 23, 2024 | $0.17876 | Dec 30, 2024 |
| Sep 24, 2024 | $0.22938 | Sep 30, 2024 |
| Jun 24, 2024 | $0.450 | Jun 28, 2024 |
News
Will Household Savings Provide An Upside Growth Surprise?
Developed-market (DM) household savings recorded a significant gain last year, with an increase equivalent to 10% of combined gross domestic product (GDP). This build-up is likely to bolster consumpti...
A Long-Term Bet For International Equity Investors
This year is shaping to be another one of U.S. equity out-performance. With five months left in 2019, the MSCI World ex USA Index is up 12.3%, badly trailing the S&P 500's 2019 gain of 21.4%.